Navigation Links
2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
Date:3/11/2009

NEW YORK, March 11 /PRNewswire-USNewswire/ -- The committee responsible for awarding the most prestigious prize in biopharmaceutical research and development -- Prix Galien USA -- announced it is accepting 2009 nominations. For the first time, the committee will include a new recognition category for best medical device. It also has expanded the eligibility window to the past decade.

Prix Galien USA is now awarded in three categories that offer broad implications for future biomedical research: best pharmaceutical agent, best biotechnology product and best medical device. All pharmaceutical and biological drugs or devices approved by the U.S. Food and Drug Administration for first or new indications between 1998 and 2008 are eligible for nomination in 2009. This new eligibility period will permit the judges to determine both the immediate and the long-term impact these pharmaceuticals, biotechnology products and devices have had on human health and disease.

"The Prix Galien USA committee is delighted to be able to honor the impact medical devices have on human health," said Gerald Weissmann, M.D., Prix Galien USA committee chair, research professor of medicine at New York University and editor-in-chief of The FASEB Journal. "When we consider how new pharmaceuticals, biotechnology products and devices have changed our lives, it is clear that we have entered a new era of medical discovery."

The committee, which includes six Nobel Laureates, will honor the ingenuity of the biopharmaceutical industry at its annual gala event on September 30 at the American Museum of Natural History in New York. Online nominations for Prix Galien USA 2009 are being accepted through June 1st http://submission.prix-galien-usa.com.

Selzentry(TM) (Pfizer Inc.), Isentress(R) (Merck & Co., Inc.), Soliris(R) (Alexion Pharmaceuticals, Inc.), INFUSE(R) (Wyeth) and Revlimid(R) (The Celgene Corporation) were recognized by the Prix Galien USA committee in 2008 for applications that address pervasive illness and diseases.

The Prix Galien Award recognizes technical, scientific and clinical research skills necessary to develop innovative medicines and devices, and is considered the industry's highest accolade -- equivalent to the Nobel Prize. The Prix Galien USA award committee comprises 11 individuals including Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. For details about the Prix Galien USA award and committee visit www.prix-galien-usa.com.


'/>"/>
SOURCE Prix Galien Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee
2. Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
3. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at Lulu.com
4. PA Governors Occupational Safety and Health Conference Still Accepting Registrations
5. UIC College of Nursing in Peoria Now Accepting Applications for New Doctorate of Nursing Practice
6. Joint Commission, National Quality Forum Now Accepting Applicants for the 2008 John M. Eisenberg Patient Safety and Quality Awards
7. Gates Foundation Now Accepting Proposals for Grand Challenges Explorations
8. SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions
9. American Sentinel University Accepting Enrollment in Online RN to BS in Nursing
10. American Pain Society Accepting Applications for Clinical Centers of Excellence in Pain Management Awards
11. PRN Funding Now Accepting Credit Cards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is ... emergency ambulance transport experience for the millions of people who require these medical ... the taxi industry through the use of technology. Now, SmartEMS has put forth ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Bay Area Lyme Foundation , ... Center for Tick Borne Illness , Harvard Medical ... Hacking Medicine, University of California, Berkeley, and the ... five finalists of Lyme Innovation , the ... 100 scientists, clinicians, researchers, entrepreneurs, and investors from ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
Breaking Medicine Technology: